Chk2 regulates transcription-independent p53-mediated apoptosis in response to DNA damage

Biochemical and Biophysical Research Communications

Volumn 333, Issue 2, 2005, Pages 427-431

  Chen, Chen ^a   Shimizu, Shigeomi ^b   Tsujimoto, Yoshihide ^b   Motoyama, Noboru ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Chk2; Histone H1; Ionizing radiation; Mitochondria; p53; Thymocytes; Transcription

Indexed keywords

CHECKPOINT KINASE 2; HISTONE H1; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; THYMOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION REGULATION; HISTONES; MICE; MITOCHONDRIA; PROTEIN-SERINE-THREONINE KINASES; RADIATION DOSAGE; RADIATION, IONIZING; THYMUS GLAND; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 20544435456     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.05.126     Document Type: Article

References (28)

1. B.B. Zhou, and S.J. Elledge The DNA damage response: putting checkpoints in perspective Nature 408 2000 433 439
2. Y. Shiloh ATM and related protein kinases: safeguarding genome integrity Nat. Rev. Cancer 3 2003 155 168
3. N. Motoyama, and K. Naka DNA damage tumor suppressor genes and genomic instability Curr. Opin. Genet. Dev. 14 2004 11 16
4. D.P. Lane Cancer. p53, guardian of the genome Nature 358 1992 15 16
5. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
6. C.A. Schmitt, J.S. Fridman, M. Yang, E. Baranov, R.M. Hoffman, and S.W. Lowe Dissecting p53 tumor suppressor functions in vivo Cancer Cell 1 2002 289 298
7. H. Symonds, L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke p53-dependent apoptosis suppresses tumor growth and progression in vivo Cell 78 1994 703 711
8. E. Appella, and C.W. Anderson Post-translational modifications and activation of p53 by genotoxic stresses Eur. J. Biochem. 268 2001 2764 2772
9. H. Takai, K. Naka, Y. Okada, M. Watanabe, N. Harada, S. Saito, C.W. Anderson, E. Appella, M. Nakanishi, H. Suzuki, K. Nagashima, H. Sawa, K. Ikeda, and N. Motoyama Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription EMBO J. 21 2002 5195 5205
10. A. Hirao, Y.Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S.J. Elledge, and T.W. Mak DNA damage-induced activation of p53 by the checkpoint kinase Chk2 Science 287 2000 1824 1827
11. A. Hirao, A. Cheung, G. Duncan, P.M. Girard, A.J. Elia, A. Wakeham, H. Okada, T. Sarkissian, J.A. Wong, T. Sakai, E. De Stanchina, R.G. Bristow, T. Suda, S.W. Lowe, P.A. Jeggo, S.J. Elledge, and T.W. Mak Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner Mol. Cell. Biol. 22 2002 6521 6532
12. M.T. Jack, R.A. Woo, A. Hirao, A. Cheung, T.W. Mak, and P.W. Lee Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response Proc. Natl. Acad. Sci. USA 99 2002 9825 9829
13. M. Mihara, S. Erster, A. Zaika, O. Petrenko, T. Chittenden, P. Pancoska, and U.M. Moll p53 has a direct apoptogenic role at the mitochondria Mol. Cell 11 2003 577 590
14. P. Dumont, J.I. Leu, A.C. Della Pietra 3rd, D.L. George, and M. Murphy The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat. Genet. 33 2003 357 365
15. J.E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N.M. Droin, D.D. Newmeyer, M. Schuler, and D.R. Green Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 303 2004 1010 1014
16. J.I. Leu, P. Dumont, M. Hafey, M.E. Murphy, and D.L. George Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex Nat. Cell Biol. 6 2004 443 450
17. A. Konishi, S. Shimizu, J. Hirota, T. Takao, Y. Fan, Y. Matsuoka, L. Zhang, Y. Yoneda, Y. Fujii, A.I. Skoultchi, and Y. Tsujimoto Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks Cell 114 2003 673 688
18. J. Falck, C. Lukas, M. Protopopova, J. Lukas, G. Selivanova, and J. Bartek Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway Oncogene 20 2001 5503 5510
19. N.H. Chehab, A. Malikzay, M. Appel, and T.D. Halazonetis Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53 Genes Dev. 14 2000 278 288
20. S.Y. Shieh, J. Ahn, K. Tamai, Y. Taya, and C. Prives The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites Genes Dev. 14 2000 289 300
21. Y.H. Ou, P.H. Chung, T.P. Sun, and S.Y. Shieh p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation Mol. Biol. Cell 2005
22. R.A. Woo, M.T. Jack, Y. Xu, S. Burma, D.J. Chen, and P.W. Lee DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53 EMBO J. 21 2002 3000 3008
23. J.J. Manfredi p53 and apoptosis: it's not just in the nucleus anymore Mol. Cell 11 2003 552 554
24. J.P. McPherson, B. Lemmers, A. Hirao, A. Hakem, J. Abraham, E. Migon, E. Matysiak-Zablocki, L. Tamblyn, O. Sanchez-Sweatman, R. Khokha, J. Squire, M.P. Hande, T.W. Mak, and R. Hakem Collaboration of Brca1 and Chk2 in tumorigenesis Genes Dev. 18 2004 1144 1153
25. M.E. Moynahan, J.W. Chiu, B.H. Koller, and M. Jasin Brca1 controls homology-directed DNA repair Mol. Cell 4 1999 511 518
26. L.C. Gowen, A.V. Avrutskaya, A.M. Latour, B.H. Koller, and S.A. Leadon BRCA1 required for transcription-coupled repair of oxidative DNA damage Science 281 1998 1009 1012
27. J.S. Larson, J.L. Tonkinson, and M.T. Lai A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells Cancer Res. 57 1997 3351 3355
28. X. Xu, Z. Weaver, S.P. Linke, C. Li, J. Gotay, X.W. Wang, C.C. Harris, T. Ried, and C.X. Deng Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells Mol. Cell 3 1999 389 395